Additionally, the FDA has confirmed that this product is eligible for 180-days of generic drug exclusivity for Ipratropium Bromide HFA Inhalation Aerosol as we were the first ANDA applicant with ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / February 24, 2026 / Amphastar Pharmaceuticals, Inc. (AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated ...

The FDA has approved a generic form of fluticasone propionate inhalation aerosol (Flovent HFA) as a prophylactic maintenance treatment for asthma, the agency announced on Tuesday. Delivered as a ...

After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial ...

A low-cost alternative for commonly used asthma medication will enter the market after pressure from Sen. Maggie Hassan.

"We are excited to announce FDA approval of Ipratropium Bromide HFA Inhalation Aerosol, reinforcing the strength of our integrated R&D and manufacturing model and demonstrating our ability to deliver ...

Maggie Hassan. The setup forced many users to pay higher prices and allowed the British drugmaker to avoid paying Medicaid rebates, the report says.

ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate ...

(RTTNews) - Glenmark Specialty SA, a subsidiary of Glenmark Pharmaceuticals Ltd. (532296) Wednesday announced that the U.S. FDA has granted final approval for its Fluticasone Propionate Inhalation ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...